Literature DB >> 8463655

Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations.

C Whitener1, G M Caputo, M R Weitekamp, A W Karchmer.   

Abstract

Coagulase-negative staphylococci are the most frequently isolated pathogens in prosthetic valve endocarditis and cause 5% of infections involving native valves. Distinguishing contamination from bacteremia may be challenging. The presence of heteroresistance in many strains makes rigorous susceptibility testing a requirement for selecting appropriate antibiotic selection. Infection is frequently complicated by valvular insufficiency with congestive heart failure, local tissue invasion or synthetic embolization, making surgical intervention necessary in many cases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463655

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  15 in total

1.  A case of endocarditis: When three equals one.

Authors:  Kiran Kaur Kundhal; Andrew Mark Morris
Journal:  Can J Infect Dis       Date:  2002-11

2.  Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.

Authors:  Kerry L LaPlante; Suzanne Woodmansee
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.

Authors:  I Anguera; A Del Río; J M Miró; X Matínez-Lacasa; F Marco; J R Gumá; G Quaglio; X Claramonte; A Moreno; C A Mestres; E Mauri; M Azqueta; N Benito; C García-de la María; M Almela; M-J Jiménez-Expósito; O Sued; E De Lazzari; J M Gatell
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

4.  Progressive Staphylococcus lugdunensis endocarditis despite antibiotic treatment.

Authors:  Michael Petzsch; Werner Leber; Bernd Westphal; Sabine Crusius; Emil C Reisinger
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

Review 5.  Recognition, management and prophylaxis of endocarditis.

Authors:  D Stamboulian; E Carbone
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

6.  Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.

Authors:  Martin E. Stryjewski; Vivian H. Chu; Christopher H. Cabell; Vance G. Fowler
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

7.  Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective.

Authors:  Cathy A Petti; Keith E Simmon; Jose M Miro; Bruno Hoen; Francesc Marco; Vivian H Chu; Eugene Athan; Suzana Bukovski; Emilio Bouza; Suzanne Bradley; Vance G Fowler; Efthymia Giannitsioti; David Gordon; Porl Reinbott; Tony Korman; Selwyn Lang; Cristina Garcia-de-la-Maria; Annibale Raglio; Arthur J Morris; Patrick Plesiat; Suzanne Ryan; Thanh Doco-Lecompte; Francesca Tripodi; Riccardo Utili; Dannah Wray; J Jeffrey Federspiel; K Boisson; L Barth Reller; David R Murdoch; Christopher W Woods
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

8.  Medical treatment of endocarditis.

Authors:  Elias Abrutyn; Christopher H Cabell; Vance G Fowler; Bruno Hoen; José M Miro; Carlos A Mestres; Daniel J Sexton; G Ralph Corey
Journal:  Curr Infect Dis Rep       Date:  2007-07       Impact factor: 3.725

9.  Deciphering genomic virulence traits of a Staphylococcus epidermidis strain causing native-valve endocarditis.

Authors:  Pierre-Edouard Fournier; Frédérique Gouriet; Grégory Gimenez; Catherine Robert; Didier Raoult
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

Review 10.  Colonization of medical devices by staphylococci.

Authors:  Yue Zheng; Lei He; Titus K Asiamah; Michael Otto
Journal:  Environ Microbiol       Date:  2018-05-06       Impact factor: 5.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.